
Alexion Pharmaceuticals, Inc. (NASDAQ:ALXN) has been recommended as a long term growth stock according to analysts at Beta Research.  With their stock price currently trading around $107.72, the firm has proven a solid track record of growth over the past few years.  Investors might consider the stock as a long term growth candidate as the firm has yielded 14.00% earnings per share growth over the past 5 years and 31.50% revenue growth over that same time frame. Long-term growth (LTG) is an investing strategy where a stock will (hopefully) grow in value for a relatively long period of time.  Long-term growth should be considered to be a relative term, due to different styles and goals of investors, but the endgame is the same. Recent PerformanceLet’s take a look at how the stock has been performing recently.  Over the past twelve months, Alexion Pharmaceuticals, Inc. (NASDAQ:ALXN)’s stock was -11.65%.  Over the last week of the month, it was -0.36%, -21.88% over the last quarter, and  10.27% for the past six months. Over the past 50 days, Alexion Pharmaceuticals, Inc.’s stock is -25.66% off of the high and 0.61% removed from the low.  Their 52-Week High and Low are as follows: -27.87% (High), 12.00%, (Low). Analyst RecommendationDespite the past success, investors want to know where the stock is headed from here.  Analysts covering the shares have a consensus short-term price target of $163.43 on the equity.   Analysts have a consensus recommendation of 1.90 based on a 1 to 5 scale where 1 represents a Strong Buy and 5 a Strong Sell.      

